4//SEC Filing
Barthel David 4
Accession 0001493152-22-003650
CIK 0001413754other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:17 PM ET
Size
8.1 KB
Accession
0001493152-22-003650
Insider Transaction Report
Form 4
MARIZYME INCMRZM
Barthel David
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2022-02-08−400,000→ 0 totalExercise: $2.25Exp: 2031-10-31→ Common Stock (400,000 underlying) - Award
Stock Options (right to buy)
2022-02-08+400,000→ 400,000 totalExercise: $1.75Exp: 2031-10-31→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted as of October 31, 2021. The option vested as to 40,000 shares upon the original option's grant date of October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021, as amended on February 8, 2022. The balance of 360,000 shares vest on a quarterly basis over the three (3) year period following October 31, 2021 in equal installments.
Documents
Issuer
MARIZYME INC
CIK 0001413754
Entity typeother
Related Parties
1- filerCIK 0001902995
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:17 PM ET
- Size
- 8.1 KB